You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Cell Therapy for the Treatment of Acute Respiratory Distress Syndrome

    SBC: ATHERSYS, INC.            Topic: NIAAA

    DESCRIPTION (provided by applicant): This is a resubmission of a Phase I-Phase II Fast-Track application for the clinical use of MultiStem in patients with acute respiratory distress syndrome (ARDS). ARDS is defined as acute onset hypoxemia, bilateral radiographic pulmonary infiltrates and lack of atrial pressure hypertension. A novel and exiting possibility is the use of cells as part of the ther ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Combinatorial RXR-based therapeutics for Alzheimer's disease

    SBC: REXCEPTOR, INC.            Topic: NIA

    DESCRIPTION (provided by applicant): The principle objective of this application is the development of safer and more effective combinatorial therapy for AD. ReXceptor, Inc. is developing new therapeutics for the treatment of AD based on stimulating the physiological clearance mechanisms of soluble forms of A from the brain. Bexarotene is an agonist of the ligand-activated transcription factor, r ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Corneal Endothelial Stem Cells for Treatment of Corneal Endothelial Dystrophies

    SBC: RASHMIVU LLC            Topic: N

    DESCRIPTION provided by applicant Corneal clouding caused by failure of the corneal endothelial deturgesence mechanism affects over million people in the US and well over million people worldwide It is the most common corneal disease and is historically a common cause of blindness Surgical treatment by corneal grafting has been successful when available but is limited by the availabili ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Corrosion Protection of High-Value Test&Evaluation Assets

    SBC: ESPIN TECHNOLOGIES, INC.            Topic: MDA13T010

    This STTR Phase I proposal proposes to design and develop reactive filter media using nanofiber technology to capture corrosion inducing particulate matter present in coastal region air. The fibrous filter media will be functionalized using ion exchange chemistry which is known to react with salt ions. The media will be characterized for its filtration performance, resistance to airflow, and dus ...

    STTR Phase I 2014 Department of DefenseMissile Defense Agency
  5. Development of Compounds for the Prevention and Treatment of Rhabdomyolysis

    SBC: Virtual Drug Development Inc.            Topic: NIDDK

    ? DESCRIPTION (provided by applicant): The goal of this Phase I STTR project is to establish the feasibility of developing a small-molecule therapeutic agent designed to prevent rhabdomyolysis-induced renal failure. Rhabdomyolysis accounts for 7% to 10% of cases of renal failure in the US. Rhabdomyolysis results from muscle injury that leads to the release of myoglobin, which is then deposited ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Dual S & C-Band Telemetry Transmitter System for Missile Testing

    SBC: Quasonix, LLC            Topic: MDA11T004

    Missile flight test telemetry has been performed at S band (2200 2395 MHz) since the 1960s. In 2007, Department of Defense test ranges acquired access to new C-band frequency ranges (4400 4950 and 5091 5150 MHz). While these new bands offer a substantial increase in the total bandwidth available for flight test telemetry, traditional S-band operations will continue for many years, due in part ...

    STTR Phase II 2014 Department of DefenseMissile Defense Agency
  7. Fabrication of Ta-Hf-C-based Ultra High Temperature Composites

    SBC: UES INC            Topic: MDA09T002

    This Phase II STTR program seeks a new fabrication method to produce stronger (>100 kpsi) and tougher (>10 MPam1/2) ultra-high temperature HfC-based composites (UHTC) with an outstanding oxidation resistance for advanced rocket nozzle throat components. UES will apply a novel"Top Down"approach to control the microstructures of the composites. This approach will produce a very unique grain structur ...

    STTR Phase II 2014 Department of DefenseMissile Defense Agency
  8. Feasibility of Non-surgical Implant Adjustment

    SBC: Apto Orthopaedics Corportation            Topic: NIAMS

    DESCRIPTION (provided by applicant): While minimally invasive surgery has transformed the practice of surgery, access to implants for removal or alteration still requires surgery which generates risk and high cost. A next-generation approach is non-invasive, where implants are adjusted without an incision. There are clear applications in all fields of surgery, but particulary in orthopaedics wher ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
  9. Novel Surface Preparation Methods for Existing Metallic Structures

    SBC: ECOSIL TECHNOLOGIES, LLC            Topic: MDA13T010

    The goal of this proposal is to demonstrate the feasibility of novel surface preparation methods that are easier to apply on metal substrates in various field environments while still enhancing the corrosion protective performance of topcoats. This is made possible by the characteristics of a patented pretreatment technology developed at Ecosil that can be spray or immersion applied. This novel ...

    STTR Phase I 2014 Department of DefenseMissile Defense Agency
  10. Targeting DNA damage response pathways for the treatment of advanced lung cancer

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: NIEHS

    DESCRIPTION (provided by applicant): There is an urgent, unmet need for novel therapeutic approaches that are efficacious against lung cancer. Ranking first among cancer deaths in the U.S., this disease has 5-year relative survival rates of lt20%. Most lung cancers are non-small cell (NSCLC, 85% of cases). Curative surgery is not an option for the 80% of NSCLC patients who present with advanced s ...

    STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government